[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Phase 1
35
about 6 years
18+
1 site in TX
Why this study is shown
What this study is about
Researchers are testing a new imaging test called [18F]PT2385 PET/CT to see if it can help doctors understand kidney cancer. This is an exploratory trial, meaning we are learning more about the test and how it works. It will involve taking biopsies of tumors in patients with kidney cancer to compare the results from the imaging test with those from a tissue sample.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take [18F]PT2385
- 2.Undergo Biopsy
- 3.Undergo Positron Emission Tomography/Computed Tomography
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
biopsy, imaging
Oncology